Julius Hallervorden

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Julius Hallervorden (21 October 1882 – 29 May 1965) was a German physician and neuroscientist. In 1938, he became the head of the Neuropathology Department of the Kaiser Wilhelm Institute for Brain Research. He was a member of the Nazi Party, and admitted to knowingly performing much of his research on the brains of executed prisoners and participated in the action T4 euthanasia program.[1]

In a conversation with Leo Alexander, a Jewish Austrian neurologist and Holocaust refugee who was forced to emigrate to the United States during World War II, Hallervorden said the following of his participation in the T4 program:

Hallervorden: "Look here now, boys. If you are going to kill all those people, at least take the brains out so that the material can be utilized.” They asked me, “ How many can you examine?” and so I told them ... the more the better".[1]

Along with Hugo Spatz, Hallervorden is credited with the discovery of Hallervorden-Spatz syndrome (now, in light of revelations of his Nazi past, more commonly referred to as Pantothenate kinase-associated neurodegeneration).[2][3] After World War II, Hallervorden became President of the German Neuropathological Society and continued his research at the Max Planck Institute in Giessen, Germany.[1]

See also[edit]


  1. ^ a b c Kondziella, D (2009). "Thirty neurological eponyms associated with the nazi era". European Neurology (Review). 62 (1): 56–64. doi:10.1159/000215880. PMID 19407456.
  2. ^ Strous, Rael D.; Morris C. Edelman (March 2007). "Eponyms and the Nazi Era: Time to Remember and Time For Change" (PDF). Israel Medical Association Journal. 9 (3): 207–214. Retrieved 2010-11-01.
  3. ^ Shevell, Michael; Jüergen Peiffer (August 2001). "Julius Hallervorden's wartime activities: implications for science under dictatorship". Pediatr Neurol. 25 (2): 162–165. PMID 11551747.